CIK 0001388320
- Non-accelerated filer
- Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880378336
- Phone
- +1 646-677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-04-14 | Nicholson, C. David Director | Purchase | +5,000 | $2.00 | $10K | 15,000 |
| 2016-04-14 | DAVE KAUSHIK J CEO and Interim CFO | Purchase | +8,000 | $2.02 | $16K | 86,500 |
| 2016-04-14 | DAVE KAUSHIK J CEO and Interim CFO | Purchase | +2,000 | $2.01 | $4K | 88,500 |
| 2016-04-14 | SETH SANDESH Director | Purchase | +5,000 | $2.00 | $10K | 15,000 |
| 2016-04-14 | Steinhart Richard I Director | Purchase | +2,500 | $2.01 | $5K | 2,500 |
| 2016-04-14 | TRAVERSA SERGIO Director | Purchase | +2,000 | $2.02 | $4K | 2,000 |
| 2013-05-15 | MAZANET ROSEMARY Director | Purchase | +100 | $3.95 | $395 | 100 |
Page 2 of 2 · 27 trades